Joshua Lewis
Affiliations: | Biomedical Engineering | Georgia Institute of Technology and Emory University, Atlanta, GA, United States |
Google:
"Joshua Lewis"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ji Z, Moore J, Devarie-Baez NO, et al. (2023) Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSM. Frontiers in Oncology. 12: 946320 |
Lewis JE, Kemp ML. (2021) Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance. Nature Communications. 12: 2700 |
Lewis JE, Forshaw TE, Boothman DA, et al. (2021) Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors. Cell Systems. 12: 68-81.e11 |
Shukla K, Singh N, Lewis JE, et al. (2020) MTHFD2 Blockade Enhances the Efficacy of β-Lapachone Chemotherapy With Ionizing Radiation in Head and Neck Squamous Cell Cancer. Frontiers in Oncology. 10: 536377 |
Paudel BB, Lewis JE, Hardeman KN, et al. (2020) An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells. Cancer Research. 80: 4565-4577 |
Forshaw TE, Holmila R, Nelson KJ, et al. (2019) Peroxiredoxins in Cancer and Response to Radiation Therapies. Antioxidants (Basel, Switzerland). 8 |
Lewis JE, Singh N, Holmila RJ, et al. (2019) Targeting NAD Metabolism to Enhance Radiation Therapy Responses. Seminars in Radiation Oncology. 29: 6-15 |
Lewis JE, Costantini F, Mims J, et al. (2017) Genome-scale modeling of NADPH-driven β-lapachone sensitization in head and neck squamous cell carcinoma. Antioxidants & Redox Signaling |